Preoperative Carbohydrate Drink Prior to Elective Caesarean Section

July 30, 2021 updated by: Ruairi Irwin, Coombe Women and Infants University Hospital

Preoperative Carbohydrate Drink Prior to Elective Caesarean Section: A Randomized Controlled Trial.

Prior to caesarean section, patients should fast from solid food for 6 hours and from clear fluids for 2 hours. Carbohydrate drinks can also be consumed up to 2 hours before surgery. These drinks have been shown to improve patient well-being after surgery and may potentially improve the neonatal blood glucose level after delivery and reduce the risk of a low blood glucose level. This study aims to assess the influence of pre-operative carbohydrate drinks on blood glucose levels of the baby at delivery.

Study Overview

Detailed Description

Patients recruited to the study will be randomised to one of 3 groups.

Group 1 will receive standard care as per our current practice. This includes fasting from solids for 6 hours prior to surgery and clear fluids for up to 2 hours prior to surgery.

Group 2 will receive a carbohydrate (CHO) drink preoperatively as well as adhering to standard care. Patients will be allowed to drink this CHO drink as required from admission to hospital on the morning of their surgery. They will also receive a further 400ml bolus at 2 hours prior to surgery.

Group 3 will receive an apple juice drink preoperatively as well as adhering to standard care. Patients will be allowed to drink this apple juice drink as required from admission to hospital on the morning of their surgery. They will also receive a further 400ml bolus at 2 hours prior to surgery.

Before the start of surgery, the patients non-dominant hand grip strength will be assessed using the dynamometer. Their subjective sense of thirst and hunger will be assessed. Their fasting times for food and fluids will be recorded. The patients' blood glucose will be measured from a blood sample as their intravenous cannula is inserted. The maternal urinary ketones will be measured from a urine sample upon insertion.

The neonatal blood cord glucose will be measured from both an arterial and venous cord blood sample after delivery. This will be performed by the trained anaesthesia research fellow. Should hypoglycemia be identified, the hospital's neonatal hypoglycemia algorithm will be followed appropriately.

The patients will be followed up at 24 hours by an outcome assessor blinded to the group allocation. Numerical rating scale (NRS) pain scores, postoperative nausea and vomiting and quality of recovery will be assessed at the patients beside. All neonates will be followed up to calculate admissions to neonatal unit and the number of glucose sachets required for hypoglycemia.

Study Type

Interventional

Enrollment (Anticipated)

69

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dublin, Ireland
        • Recruiting
        • Coombe Women and Infants University Hospital
        • Contact:
          • Ruairi Irwin
          • Phone Number: 014085200

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Elective caesarean section for singleton pregnancy under neuraxial anaesthesia.
  • Subjects able to give informed consent and willing to comply with the study protocol.
  • Subjects must be greater than 18 years old.

Exclusion Criteria:

  • Diabetes Mellitus - including gestational diabetes.
  • Known foetal abnormality.
  • General anaesthesia.
  • Gestation < 37 weeks.
  • Steroids received within 4 days of delivery.
  • Low birth weight 2.5 kg (IUGR)
  • BMI > 40 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Water
Patients will be allowed to drink water up to 2 hours before their caesarean section.
This is a commercially available "pre-op" carbohydrate drink used in enhanced recovery programmes.
Active Comparator: Carbohydrate drink
Patients will be allowed to drink a designated carbohydrate drink up to 2 hours before their caesarean section.
This is a commercially available "pre-op" carbohydrate drink used in enhanced recovery programmes.
Active Comparator: Apple juice
Patients will be allowed to drink apple juice up to 2 hours before their caesarean section.
This is a commercially available "pre-op" carbohydrate drink used in enhanced recovery programmes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal cord blood glucose
Time Frame: 0 hours
A blood sample of the neonatal cord will be checked immediately after delivery.
0 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonate tolerating 1st oral feeding.
Time Frame: 0-2 hours
Binary outcome - Neonate consuming adequate breast or bottle milk.
0-2 hours
Number of neonatal rescue oral glucose sachets given.
Time Frame: 6 hours
Continuous - Number of neonatal rescue oral glucose sachets given.
6 hours
Neonate requiring ICU admission and treatment for hypoglycemia
Time Frame: 6 hours
Binary - Neonate requiring ICU admission and treatment for hypoglycemia
6 hours
Maternal blood glucose
Time Frame: 0 hours
Maternal blood glucose prior to the start of caesarean section.
0 hours
Maternal urinary ketones
Time Frame: 0 hours
Maternal urinary ketones prior to the start of caesarean section.
0 hours
Maternal subjective sense of thirst prior to the start of caesarean section.
Time Frame: 0 hours
Scored on a scale 0-10
0 hours
Maternal subjective sense of hunger prior to the start of caesarean section.
Time Frame: 0 hours
Scored on a scale 0-10
0 hours
Maternal quality of recovery
Time Frame: 24 hours
Measured using the ObsQoR-11 questionnaire
24 hours
Resumption of oral diet post caesarean section.
Time Frame: 24 hours
Time until resumption of oral diet
24 hours
Resumption of fluids post caesarean section.
Time Frame: 24 hours
Time until resumption of fluids
24 hours
Post-operative nausea and vomiting (PONV)
Time Frame: 24 hours
The self reported incidence of PONV
24 hours
PONV requiring treatment
Time Frame: 24 hours
PONV requiring pharmacological treatment
24 hours
Pain scores
Time Frame: 24 hours
Pain scores at rest and movement on scale 0-10
24 hours
Breastfeeding success
Time Frame: 24 hours
Binary - whether continuing attempted breast feeding at 24 hours
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Terry Tan, Head of Department of Anaesthesia CWIUH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2020

Primary Completion (Anticipated)

August 10, 2021

Study Completion (Anticipated)

August 10, 2021

Study Registration Dates

First Submitted

November 8, 2019

First Submitted That Met QC Criteria

November 8, 2019

First Posted (Actual)

November 12, 2019

Study Record Updates

Last Update Posted (Actual)

August 2, 2021

Last Update Submitted That Met QC Criteria

July 30, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • CWIUH-CHO (16-2019)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fasting

Clinical Trials on Carbohydrate drink

3
Subscribe